$SEPN 4 SEC Filings

Filed On	Filing
19 Oct 2026	Form 4: Bhatt Elizabeth, President and COO Received 4,000 shares by exercise or conversion ($27.2K) · Sold 4,000 shares ($150K)
10 Sep 2026	Form 4: Patni Rajiv, Chief Medical Officer Granted 275,000 Stock Option (Right to Buy)
03 Sep 2026	Form 4: Long Daniel D., SVP, Drug Discovery Received 3,333 shares by exercise or conversion ($9.2K) · Sold 3,333 shares ($126K)
14 Aug 2026	Form 4: Third Rock Ventures V, L.p., 10% owner and 5 others Acquired 147,200 shares (Open Market Sale) ($7.4M)
14 Aug 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Sold 1,493,000 shares ($63.5M)
13 Aug 2026	Form 4: Bhatt Elizabeth, President and COO Received 25,000 shares by exercise or conversion ($145K) · Sold 25,000 shares ($1.1M)
05 Aug 2026	Form 4: Long Daniel D., SVP, Drug Discovery Received 3,334 shares by exercise or conversion ($9.2K) · Sold 3,334 shares ($115K)
17 Jul 2026	Form 4: Bhatt Elizabeth, President and COO Received 4,000 shares by exercise or conversion ($27.2K) · Sold 4,000 shares ($136K)
02 Jul 2026	Form 4: Long Daniel D., SVP, Drug Discovery Received 3,333 shares by exercise or conversion ($9.2K) · Sold 3,333 shares ($115K)
30 Jun 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Granted 15,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Shaikhly Samira, Chief People Officer Received 2,178 shares by exercise or conversion ($14.8K) · Sold 2,178 shares ($76.6K)
30 Jun 2026	Form 4: Bassan Abraham, Director Granted 15,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Sharp Shalini, Director Granted 15,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Coulie Bernard, Director Granted 15,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Tong Jeffrey K, Director Granted 15,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Gottesdiener Keith Michael, Director Granted 11,260 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Ezekowitz Alan, Director Granted 15,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Simson Jake, Director Granted 15,000 Stock Option (Right to Buy)
24 Jun 2026	Form 4: Long Daniel D., SVP, Drug Discovery Received 15,000 shares by exercise or conversion ($81.4K) · Sold 15,000 shares ($533K)
16 Jun 2026	Form 4: Shaikhly Samira, Chief People Officer Received 6,250 shares by exercise or conversion ($73.1K) · Sold 6,250 shares ($219K)

Comments